Repetitive Thoughts in Fibromyalgia: Impact of Rumination on the Emotional and Cognitive Dimensions of Fibromyalgia

Fibromyalgia Clinical Trial

— PRFM-1  

Official title:

Repetitive Thoughts in Fibromyalgia: Impact of Rumination on the Emotional and Cognitive Dimensions of Fibromyalgia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03133455
• Other study ID #: PI2015_843_0024
• Status: Completed
• Phase: N/A
• Start date: September 16, 2015
• Est. completion date: November 26, 2017

Study information

• Verified date: August 2018
• Source: Centre Hospitalier Universitaire, Amiens
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Dysfunctional chronic diffuse pain syndrome, concerning 2% of the French population, Fibromyalgia (FM) is classified either as a psychological disease or as a somatic disease. This dichotomous reasoning does not lead to a better understanding and does not allow the use or development of new psychological tools of care.

The issue of the proximity between FM and depression highlighted by some authors and the presence of anxious comorbidities may arise at a different level, that of the transdiagnostic approach. Rumination is one of these transdiagnostic processes that are the subject of recent studies and one of the dimensions of which (abstract analytical rumination) is at work in depression and a number of psychopathologies. The investigator therefore wishes to explore the process of rumination and its abstract analytical dimension in FM and to explore its link with the depressive and anxious manifestations frequently associated with this disorder.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 107
• Est. completion date: November 26, 2017
• Est. primary completion date: November 26, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• FM Criteria of the American College of Rheumatology ACR 1990.

• Major Patients

• free and informed consent signed

• stable treatment for at least one month

• Native French speaker

• Patient covered by health insurance.

Exclusion Criteria:

• Patient deprived of liberty or protected major (under guardianship or curatorship)

Related Conditions & MeSH terms

• Fibromyalgia
• Myofascial Pain Syndromes

Intervention

Other:
• Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.
Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.

Locations

Country	Name	City	State
France	CHU Amiens Picardie	Amiens	Picardie

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Analyze the rate of rumination and depression of a fibromyalgia patient using a questionnaire	Analyze the rate of rumination and depression of a fibromyalgia patient using a questionnaire	1 hour